Dr. Chari on the Use of Frontline Daratumumab in Transplant-Eligible Patients With Myeloma
August 8th 2019Ajai Chari, MD, associate professor, hematology and medical oncology, Mount Sinai Hospital, discusses the use of frontline daratumumab (Darzalex) in transplant-eligible patients with multiple myeloma.
Read More